Clinical trial
Zileuton for the Treatment of Idiopathic Pulmonary Fibrosis
NCT00262405 · University of Michigan, Other · Completed
Key facts
| NCT number | NCT00262405 |
|---|---|
| Title | Zileuton for the Treatment of Idiopathic Pulmonary Fibrosis |
| Official title | Phase II Trial of Zileuton Compared to Azathioprine/Prednisone for the Treatment of Idiopathic Pulmonary Fibrosis |
| Lead sponsor | University of Michigan, Other |
| Collaborators | National Institutes of Health (NIH) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Idiopathic Pulmonary Fibrosis |
| Intervention type | Drug |
| Interventions | zileuton, azathioprine/prednisone |
| Enrollment | 44 |
| Start date | Jan 1, 2001 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Dec 6, 2005 |
| Last update posted | Dec 3, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: